More than one in five UK adults tried to access weight-loss medications in the past year alone, according to a survey by the National Pharmacy Association.

Novo Nordisk A/S (NYSE:NVO) is among the. Novo Nordisk A/S (NYSE:NVO) lowered its operating profit growth projections to 10–16% (from 16-24%) and revenue growth projections to 8-14% (from 13-21%) at ...

Pete A Williams, Ulla and Ingemar Dahlberg Professor in Vision Science, Research Group Leader, Karolinska Institutet A new study shows drugs such as Ozempic come with a small but increased risk of a ...

SALT LAKE CITY — It was a first-of-its-kind study conducted at the University of Utah on a drug that has, to date, changed ...

At Lollapalooza 2025, Rebecca Black took the stage in an risqué dress that had everyone talking. See her jaw-dropping corset ...

Researchers see good in popular drug, but hope findings lead to more study on how it could cause muscle weakness ...

Chinese drugmakers are racing to roll out cheaper or more innovative alternatives. Read more at straitstimes.com. Read more ...

When researchers tested the amount of force exerted by mice, they found that some showed a decrease in strength, despite ...

Jelly Roll is celebrating every milestone. The Country singer has been committed to his health and in managing his food ...

Scientists are looking into alternative weight loss solutions beyond GLP-1 medications like Mounjaro, Ozempic and Wegovy ...

If you’re pregnant or hoping to become pregnant, it’s natural to have questions about your medications. And if you’re taking ...

Novo Nordisk's FY 2025 guidance cuts are driven by softer U.S. Wegovy/Ozempic and GLP-1 trends. Click here to find out why I ...